- Home
- CFR vs CAI Comparison
CFR vs CAI Comparison
Compare CFR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | CAI |
|---|---|---|
| Founded | 1868 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 6.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CFR | CAI |
|---|---|---|
| Price | $133.16 | $18.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $143.08 | $33.67 |
| AVG Volume (30 Days) | 539.2K | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.72 | $24.26 |
| Revenue Next Year | $4.70 | $22.60 |
| P/E Ratio | $14.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $100.31 | $17.15 |
| 52 Week High | $148.97 | $42.50 |
Technical Indicators
Market Signals| Indicator | CFR | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 33.49 | 37.42 |
| Support Level | $121.94 | $17.15 |
| Resistance Level | $146.95 | $21.47 |
| Average True Range (ATR) | 3.39 | 1.26 |
| MACD | -1.33 | 0.12 |
| Stochastic Oscillator | 6.50 | 33.33 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $53 billion in assets (as of September 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.